Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Moses, Mark W ^a   Zwerling, Alice ^a   Cattamanchi, Adithya ^b   Denkinger, Claudia M ^c   Banaei, Niaz ^d   Kik, Sandra V ^e   Metcalfe, John ^b   Pai, Madhukar ^f   Dowdy, David ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c FIND   (Switzerland)

^d STANFORD UNIVERSITY   (United States)

^e KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; FALSE POSITIVE RESULT; FEMALE; HEALTH CARE PERSONNEL; HEALTH SERVICE; HUMAN; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MALE; MARKOV CHAIN; MASS SCREENING; NORTH AMERICA; PROCEDURES; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

COHORT STUDIES; FALSE POSITIVE REACTIONS; FEMALE; HEALTH PERSONNEL; HUMANS; INCIDENCE; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MARKOV CHAINS; MASS SCREENING; MEDICAL OVERUSE; MODELS, STATISTICAL; NORTH AMERICA; SENSITIVITY AND SPECIFICITY;

EID: 84979917784     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30781     Document Type: Article

References (31)

1. Jensen, P. A., Lambert, L. A., Iademarco, M. F., Ridzon, R. C. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control 54, 1-141 (2005).
2. Linas, B. P., Wong, A. Y., Freedberg, K. A., Horsburgh, C. R. Jr. Priorities for screening and treatment of latent tuberculosis infection in the United States. American journal of respiratory and critical care medicine 184, 590-601, doi: 10.1164/rccm.201101-0181OC (2011).
3. Mazurek, G. H. et al. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control 59, 1-25 (2010).
4. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control 49, 1-51 (2000).
5. Pai, M. et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. American journal of respiratory and critical care medicine 174, 349-355, doi: 10.1164/rccm.200604-472OC (2006).
6. Pai, M., Menzies, D. The new IGRA and the old TST: making good use of disagreement. American journal of respiratory and critical care medicine 175, 529-531, doi: 10.1164/rccm.200701-024ED (2007).
7. Pai, M., Zwerling, A., Menzies, D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149, 177-184 (2008).
8. Dorman, S. E. et al. Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. American journal of respiratory and critical care medicine 189, 77-87, doi: 10.1164/rccm.201302-0365OC (2014).
9. Fong, K. S. et al. Challenges of Interferon-gamma Release Assay Conversions in Serial Testing of Health Care Workers in a Tuberculosis Control Program. Chest, doi: 10.1378/chest.11-0992 (2012).
10. Joshi, M., Monson, T. P., Woods, G. L. Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States. Canadian respiratory journal: journal of the Canadian Thoracic Society 19, 84-88 (2012).
11. LoBue, P. A., Catanzaro, A. Effectiveness of a nosocomial tuberculosis control program at an urban teaching hospital. Chest 113, 1184-1189 (1998).
12. Pai, M., Elwood, K. Interferon-gamma release assays for screening of health care workers in low tuberculosis incidence settings: dynamic patterns and interpretational challenges. Canadian respiratory journal: journal of the Canadian Thoracic Society 19, 81-83 (2012).
13. Zwerling, A. et al. Repeat IGRA Testing in Canadian Health Workers: Conversions or Unexplained Variability? PloS one 8, e54748, doi: 10.1371/journal.pone.0054748 (2013).
14. Banaei, N., Gaur, R. L., Pai, M. Interferon-gamma release assays for latent tuberculosis: what are the sources of variability? Journal of clinical microbiology, doi: 10.1128/JCM.02803-15 (2016).
15. Tagmouti, S. et al. Reproducibility of interferon gamma (IFN-gamma) release Assays. A systematic review. Annals of the American Thoracic Society 11, 1267-1276, doi: 10.1513/AnnalsATS.201405-188OC (2014).
16. Blumberg, H. M. et al. Preventing the nosocomial transmission of tuberculosis. Ann Intern Med 122, 658-663 (1995).
17. Lambert, L. A., Pratt, R. H., Armstrong, L. R., Haddad, M. B. Tuberculosis among healthcare workers, United States, 1995-2007. Infection control and hospital epidemiology 33, 1126-1132, doi: 10.1086/668016 (2012).
18. Gandra, S. et al. Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers. Infection control and hospital epidemiology 31, 1279-1285, doi: 10.1086/657336 (2010).
19. Gaur, R. L., Pai, M., Banaei, N. Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERONTB gold in-tube assay. Journal of clinical microbiology 51, 3521-3526, doi: 10.1128/JCM.01627-13 (2013).
20. Doberne, D., Gaur, R. L., Banaei, N. Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection. Journal of clinical microbiology 49, 3061-3064, doi: 10.1128/JCM.01136-11 (2011).
21. Herrera, V., Yeh, E., Murphy, K., Parsonnet, J., Banaei, N. Immediate incubation reduces indeterminate results for QuantiFERONTB Gold in-tube assay. Journal of clinical microbiology 48, 2672-2676, doi: 10.1128/JCM.00482-10 (2010).
22. Baker, C. A., Thomas, W., Stauffer, W. M., Peterson, P. K., Tsukayama, D. T. Serial testing of refugees for latent tuberculosis using the QuantiFERON-gold in-tube: effects of an antecedent tuberculin skin test. The American journal of tropical medicine and hygiene 80, 628-633 (2009).
23. Cummings, K. J. et al. Prospective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting. Infection control and hospital epidemiology 30, 1123-1126, doi: 10.1086/644754 (2009).
24. Ritz, N. et al. Absence of interferon-gamma release assay conversion following tuberculin skin testing. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 15, 767-769, doi: 10.5588/ijtld.10.0339 (2011).
25. Ringshausen, F. C. et al. Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers. Clinical and vaccine immunology: CVI 18, 1176-1182, doi: 10.1128/CVI.05058-11 (2011).
26. Oxlade, O., Schwartzman, K., Menzies, D. Interferon-gamma release assays and TB screening in high-income countries: a costeffectiveness analysis. The International Journal of Tuberculosis and Lung Disease 11, 16-26 (2007).
27. Marks, S. M. et al. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007. Emerg Infect Dis 20, 812-821 (2014).
28. Sterling, T. R. et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. New England Journal of Medicine 365, 2155-2166 (2011).
29. Daley, C. L. et al. A summary of meeting proceedings on addressing variability around the cut point in serial interferon-gamma release assay testing. Infection control and hospital epidemiology 34, 625-630, doi: 10.1086/670635 (2013).
30. Slater, M. L., Welland, G., Pai, M., Parsonnet, J., Banaei, N. Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. American journal of respiratory and critical care medicine 188, 1005-1010, doi: 10.1164/rccm.201305-0831OC (2013).
31. Thanassi, W. et al. Delineating a Retesting Zone Using Receiver Operating Characteristic Analysis on Serial QuantiFERON Tuberculosis Test Results in US Healthcare Workers. Pulmonary medicine 2012, 291294, doi: 10.1155/2012/291294 (2012).